Viren Mehta - Net Worth and Insider Trading
Viren Mehta Net Worth
The estimated net worth of Viren Mehta is at least $10,385 dollars as of 2024-04-28. Viren Mehta is the Director of Traws Pharma Inc and owns about 16,731 shares of Traws Pharma Inc (TRAW) stock worth over $10,385. Details can be seen in Viren Mehta's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Viren Mehta has not made any transactions after 2019-11-25 and currently still holds the listed stock(s).
Transaction Summary of Viren Mehta
Viren Mehta Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Viren Mehta owns 1 companies in total, including Traws Pharma Inc (TRAW) .
Click here to see the complete history of Viren Mehta’s form 4 insider trades.
Insider Ownership Summary of Viren Mehta
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| TRAW | Traws Pharma Inc | 2019-11-25 | director |
Viren Mehta Latest Holdings Summary
Viren Mehta currently owns a total of 1 stock. Viren Mehta owns 16,731 shares of Traws Pharma Inc (TRAW) as of November 25, 2019, with a value of $10,385.
Latest Holdings of Viren Mehta
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| TRAW | Traws Pharma Inc | 2019-11-25 | 16,731 | 0.62 | 10,385 |
Holding Weightings of Viren Mehta
Viren Mehta Form 4 Trading Tracker
According to the SEC Form 4 filings, Viren Mehta has made a total of 1 transactions in Traws Pharma Inc (TRAW) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Traws Pharma Inc is the acquisition of 16,667 shares on November 25, 2019, which cost Viren Mehta around $50,000.
Insider Trading History of Viren Mehta
- 1
Viren Mehta Trading Performance
GuruFocus tracks the stock performance after each of Viren Mehta's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Viren Mehta is 112.4%. GuruFocus also compares Viren Mehta's trading performance to market benchmark return within the same time period. The performance of stocks bought by Viren Mehta within 3 months outperforms 1 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Viren Mehta's insider trading performs compared to the benchmark.
Performance of Viren Mehta
Average Return
6.11%
Outperforming Transactions
50%
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 61.39 | 112.4 | 83.14 | 6.11 | -21.99 | -50.73 |
| Relative Return to S&P 500(%) | 61.53 | 110.19 | 82.78 | -10.21 | -39.15 | -59.5 |
Viren Mehta Ownership Network
Ownership Network List of Viren Mehta
Ownership Network Relation of Viren Mehta
Viren Mehta Owned Company Details
What does Traws Pharma Inc do?
Who are the key executives at Traws Pharma Inc?
Viren Mehta is the director of Traws Pharma Inc. Other key executives at Traws Pharma Inc include CHIEF MEDICAL OFFICER Victor M Moyo , VP Corp Dev & Gen Counsel Abraham N. Oler , and Chief Medical Officer Steven M Fruchtman .
Traws Pharma Inc (TRAW) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Traws Pharma Inc (TRAW) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Traws Pharma Inc (TRAW) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Traws Pharma Inc (TRAW)'s detailed insider trading history can be found in Insider Trading Tracker table.
Traws Pharma Inc Insider Transactions
Viren Mehta Mailing Address
Above is the net worth, insider trading, and ownership report for Viren Mehta. You might contact Viren Mehta via mailing address: Osi Pharmaceuticals Inc, 58 S Service Rd Ste 110, Melville Ny 11747.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
